Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 4
1964 12
1968 2
1971 1
1972 1
1973 2
1974 2
1975 1
1977 1
1978 1
1979 4
1980 2
1981 3
1982 2
1983 6
1984 6
1985 7
1986 6
1987 7
1988 9
1989 7
1990 5
1991 13
1992 16
1993 13
1994 15
1995 24
1996 19
1997 24
1998 13
1999 22
2000 17
2001 29
2002 21
2003 37
2004 31
2005 44
2006 49
2007 62
2008 46
2009 45
2010 59
2011 58
2012 73
2013 80
2014 99
2015 90
2016 118
2017 107
2018 123
2019 123
2020 148
2021 128
2022 135
2023 110
2024 104
2025 146
2026 88

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,118 results

Results by year

Filters applied: . Clear all
Page 1
Correlation Between CT-Derived Bhalla Score and Lung Ultrasound Score in Adult Patients with Cystic Fibrosis.
Stoicescu R, Iacob ER, Stoicescu ER, Manolescu D, Oancea C, Crisan A, Maritescu A, Ioana AM, Constantinescu A, Pescaru CC. Stoicescu R, et al. Diagnostics (Basel). 2026 Jun 3;16(11):1722. doi: 10.3390/diagnostics16111722. Diagnostics (Basel). 2026. PMID: 42279590
Background/Objectives: Cystic fibrosis is a chronic multisystem disease in which pulmonary involvement is the main determinant of morbidity and mortality. ...Methods: A prospective cohort study was conducted including adult patients with cystic fibr …
Background/Objectives: Cystic fibrosis is a chronic multisystem disease in which pulmonary involvement is the main dete …
Sinonasal and Pulmonary Computed Tomography Images Before and After Triple-Combination Therapy in a Patient with Cystic Fibrosis Without deltaF508 Mutations.
Tagliati C, Campagna G, Di Sabatino M, Lanni G, Battista D, Ripani P. Tagliati C, et al. Diagnostics (Basel). 2026 May 30;16(11):1692. doi: 10.3390/diagnostics16111692. Diagnostics (Basel). 2026. PMID: 42279560
Here, we present the case of a 25-year-old patient with G542X and G85E cystic fibrosis mutations who underwent computed tomography examination before and after triple-combination therapy. Clear improvement in sinonasal and lung involvement is vi …
Here, we present the case of a 25-year-old patient with G542X and G85E cystic fibrosis mutations who underwent computed …
Mycobacterium abscessus infection in a young man with cystic fibrosis: a case report and literature review.
Luo L, Guo Z, Chen W, Zheng Y, Chen C, Li Q, Wang N, Ji Y, Hua J. Luo L, et al. Front Pediatr. 2026 May 26;14:1737211. doi: 10.3389/fped.2026.1737211. eCollection 2026. Front Pediatr. 2026. PMID: 42272701 Free PMC article.
BACKGROUND: Cystic fibrosis (CF) is a rare autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. ...CASE REPORT: A 21-year-old man presented with a 6-year history of recurrent productiv …
BACKGROUND: Cystic fibrosis (CF) is a rare autosomal recessive disorder caused by mutations in the cystic fibrosis …
CT assessment of body composition and lung evolution in cystic fibrosis after Elexacaftor-Tezacaftor-Ivacaftor: A cohort study.
Soria-Utrilla V, Piñar-Gutiérrez A, Sánchez-Torralvo FJ, Adarve-Castro A, Padial M, Jiménez-Sánchez A, Quintana-Gallego ME, Olveira C, Girón MV, Olveira G, García-Luna PP. Soria-Utrilla V, et al. Respir Med. 2026 Jun 6;260:108942. doi: 10.1016/j.rmed.2026.108942. Online ahead of print. Respir Med. 2026. PMID: 42251917
BACKGROUND: Elexacaftor-Tezacaftor-Ivacaftor (ETI) therapy markedly improves pulmonary function in people with cystic fibrosis (pwCF) but induces weight gain, raising concerns about body composition. CT scans routinely performed to assess lung s …
BACKGROUND: Elexacaftor-Tezacaftor-Ivacaftor (ETI) therapy markedly improves pulmonary function in people with cystic fibro …
Radiologic progression with minimal functional decline in cystic fibrosis: Insights from a prospective study.
Suhail JM, Wagay MI, Parry AH, Bhat IM, Sheikh RR, Bhat MA. Suhail JM, et al. World J Radiol. 2026 May 28;18(5):117936. doi: 10.4329/wjr.v18.i5.117936. World J Radiol. 2026. PMID: 42238223 Free PMC article.
BACKGROUND: Timely identification and monitoring of lung disease progression are key components of effective management in patients with cystic fibrosis (CF). Pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT) …
BACKGROUND: Timely identification and monitoring of lung disease progression are key components of effective management in patients w …
Oxygen-enhanced MRI and multiple breath washout with Short extension reveal cystic fibrosis lung disease progression despite triple modulator therapy.
Short C, Semple T, Abkir M, Efthyvoulou C, Padley S, Rosenthal M, McNally P, Tiddens H, Caudri D, Tibiletti M, Parker GJ, Davies JC. Short C, et al. Thorax. 2026 Jun 3:thorax-2025-224648. doi: 10.1136/thorax-2025-224648. Online ahead of print. Thorax. 2026. PMID: 42235961
INTRODUCTION: The current cystic fibrosis (CF) care era, while hugely welcome, raises new challenges, particularly the need for more sensitive pulmonary outcome measures. ...OE-MRI/MBW(ShX) reveal the likely less welcome reality that lung-diseas …
INTRODUCTION: The current cystic fibrosis (CF) care era, while hugely welcome, raises new challenges, particularly the need fo …
Ultrasound elastography in pediatric care: bridging innovation and noninvasive diagnostics.
Piersanti M, Ferrari F, Piccirillo M, Agostiniani R, Zerunian M, Caruso D, Civitelli F, Graziani M, Parisi P, Cortis E, Di Nardo G, Mennini M. Piersanti M, et al. Ital J Pediatr. 2026 Jun 2. doi: 10.1186/s13052-026-02279-6. Online ahead of print. Ital J Pediatr. 2026. PMID: 42231359 Free article. Review.
It also provides an overview of new potential applications in kidney diseases, inflammatory bowel disease, cystic fibrosis, and muscle disorders. Two-dimensional shear wave elastography (2D-SWE) demonstrates excellent diagnostic accuracy in liver disease. ...Emergin …
It also provides an overview of new potential applications in kidney diseases, inflammatory bowel disease, cystic fibrosis, an …
Comparison of Long Term Effects of Treatment of Different CFTR Modulators in People With Cystic Fibrosis.
Famulska P, Więckowska B, Narożna B, Sapiejka E, Osińska M, Musiał A, Szczepankiewicz A, Tąpolska-Jóźwiak K, Wiesner A, Steinert-Dymecki A, Jóźwiak M, Wojsyk-Banaszak I. Famulska P, et al. Pediatr Pulmonol. 2026 Jun;61(6):e71681. doi: 10.1002/ppul.71681. Pediatr Pulmonol. 2026. PMID: 42206906
BACKGROUND: Cystic fibrosis transmembrane conductance regulator modulators (CFTRm) represent a breakthrough in the treatment of people with cystic fibrosis (PwCF), offering improvements in health outcomes and quality of life (QoL) previously unattainab …
BACKGROUND: Cystic fibrosis transmembrane conductance regulator modulators (CFTRm) represent a breakthrough in the treatment o …
Association of German Bronchiectasis Registry participation with disease course.
Rademacher J, Ringshausen FC, Sutharsan S, Rohde G, Zurawski A, Sieber S, Barten-Neiner G, Adaskina N, Pink I, Mertsch P. Rademacher J, et al. ERJ Open Res. 2026 May 26;12(3):01121-2025. doi: 10.1183/23120541.01121-2025. eCollection 2026 May. ERJ Open Res. 2026. PMID: 42206015 Free PMC article.
BACKGROUND: Bronchiectasis research has advanced significantly through international and national registries, such as the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) registry, revealing crucial insights into the disease's heterogene …
BACKGROUND: Bronchiectasis research has advanced significantly through international and national registries, such as the European Mu …
Fractional Exhaled Nitric Oxide in Children with Non-Cystic Fibrosis Bronchiectasis: Associations with Etiology, Lung Function, and CT Extent.
Adiguzel T, Karadag B. Adiguzel T, et al. Pediatr Rep. 2026 May 1;18(3):62. doi: 10.3390/pediatric18030062. Pediatr Rep. 2026. PMID: 42201195 Free PMC article.
BACKGROUND/OBJECTIVES: Childhood non-cystic fibrosis (non-CF) bronchiectasis is clinically heterogeneous. We aimed to describe fractional exhaled nitric oxide (FeNO) levels in affected children and examine associations with etiology, spirometry, and CT …
BACKGROUND/OBJECTIVES: Childhood non-cystic fibrosis (non-CF) bronchiectasis is clinically heterogeneous. We aimed to d …
2,118 results